Pieris Pharmaceuticals Inc has appointed Louis Matis as chief development officer to oversee clinical studies of the company’s protein therapeutics for anaemia, asthma and immuno-oncology. Dr Matis was previously head of strategic evaluation at Alexion Pharmaceuticals Inc and was also chief executive officer of CGI Pharmaceuticals Inc (Gilead Sciences).
He has held senior research and clinical positions at the US National Institutes of Health and the Food and Drug Administration. Dr Matis holds a BA from Amherst College and an MD from the University of Pennsylvania, Perelman School of Medicine.
Pieris announced the appointment on 18 August 2015.
Copyright 2014 Evernow Publishing Ltd